0
selected
-
1.
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product.
Taddei, ML, Pietrovito, L, Leo, A, Chiarugi, P
Cells. 2020;(2)
Abstract
Sarcomas are rare and heterogeneous malignant tumors relatively resistant to radio- and chemotherapy. Sarcoma progression is deeply dependent on environmental conditions that sustain both cancer growth and invasive abilities. Sarcoma microenvironment is composed of different stromal cell types and extracellular proteins. In this context, cancer cells may cooperate or compete with stromal cells for metabolic nutrients to sustain their survival and to adapt to environmental changes. The strict interplay between stromal and sarcoma cells deeply affects the extracellular metabolic milieu, thus altering the behavior of both cancer cells and other non-tumor cells, including immune cells. Cancer cells are typically dependent on glucose fermentation for growth and lactate is one of the most heavily increased metabolites in the tumor bulk. Currently, lactate is no longer considered a waste product of the Warburg metabolism, but novel signaling molecules able to regulate the behavior of tumor cells, tumor-stroma interactions and the immune response. In this review, we illustrate the role of lactate in the strong acidity microenvironment of sarcoma. Really, in the biological context of sarcoma, where novel targeted therapies are needed to improve patient outcomes in combination with current therapies or as an alternative treatment, lactate targeting could be a promising approach to future clinical trials.
-
2.
Lactic Acid Fermentation of Cereals and Pseudocereals: Ancient Nutritional Biotechnologies with Modern Applications.
Petrova, P, Petrov, K
Nutrients. 2020;(4)
Abstract
Grains are a substantial source of macronutrients and energy for humans. Lactic acid (LA) fermentation is the oldest and most popular way to improve the functionality, nutritional value, taste, appearance and safety of cereal foods and reduce the energy required for cooking. This literature review discusses lactic acid fermentation of the most commonly used cereals and pseudocereals by examination of the microbiological and biochemical fundamentals of the process. The study provides a critical overview of the indispensable participation of lactic acid bacteria (LAB) in the production of many traditional, ethnic, ancient and modern fermented cereals and beverages, as the analysed literature covers 40 years. The results reveal that the functional aspects of LAB fermented foods are due to significant molecular changes in macronutrients during LA fermentation. Through the action of a vast microbial enzymatic pool, LAB form a broad spectrum of volatile compounds, bioactive peptides and oligosaccharides with prebiotic potential. Modern applications of this ancient bioprocess include the industrial production of probiotic sourdough, fortified pasta, cereal beverages and "boutique" pseudocereal bread. These goods are very promising in broadening the daily menu of consumers with special nutritional needs.
-
3.
Does Low-Level Laser Therapy Decrease Muscle-Damaging Mediators After Performance in Soccer Athletes Versus Sham Laser Treatment? A Critically Appraised Topic.
Bettleyon, J, Kaminski, TW
Journal of sport rehabilitation. 2020;(8):1210-1213
Abstract
Clinical Scenario: Low-level laser therapy (LLLT) is a controversial topic for its use in athletic recovery, mainly due to inconsistency in research regarding the application of LLLT. Articles on LLLT have assessed its effectiveness in untrained humans through pain scales, functional scales, and blood draws, and it has been found capable in nonathletic rehabilitative use. The controversy lies with LLLT in the recovering athlete. Not only do athletes need to perform at high levels, but each sport is unique in the metabolic demands placed on the athletes' bodies. This modality can alter chemical mediators of the inflammatory process, specifically blood lactate (BL) and creatine kinase (CK). During soccer contests, it is a common problem for athletes to have an average CK level of 800 U/L and BL of 8 mmol·L, increasing delayed-onset muscle soreness and fatigue. Micro-CK level elevation is associated with cellular membrane damage, localized hypoxia, and electrolyte imbalances, hindering the recovery process. Clinical Question: Does LLLT decrease muscle-damaging mediators effecting player fatigue and delayed-onset muscle soreness after performance in soccer athletes versus sham treatment? Summary of Key Findings: In 3 studies, preperformance, postperformance, or preperformance and postperformance LLLT was performed and evaluated BL (2 of 3) and CK (2 of 3). In each article, BL and CK showed a significant decrease (P < .05) when performed either preperformance or postperformance versus the control group. The greatest decrease in these mediators was noticed when postperformance laser therapy was performed. Clinical Bottom Line: LLLT at 10, 30, or 50 J performed at a minimum of 2 locations on the rectus femoris, vastus lateralis, and vastus medialis bilaterally for 10 seconds each is significant in decreasing blood serum levels of BL and CK when performed postexercise. Strength of Recommendations: All 3 articles obtained a Physiotherapy Evidence Database score of ≥8/10.
-
4.
Engineering Tools for the Development of Recombinant Lactic Acid Bacteria.
Cho, SW, Yim, J, Seo, SW
Biotechnology journal. 2020;(6):e1900344
Abstract
Lactic acid bacteria (LAB) is mainly used in food fermentation. In addition, LAB fermentation technology has been studied in the development of industrial food additives, nutrients, or enzymes used in food processing. In the field of red biotechnology, LAB is approved and is generally recognized as a safe organism and is considered safe for biotherapeutic treatments. Recent clinical trials have demonstrated the medicinal value of therapeutic recombinant LAB and the suitability of innate mechanisms of secretion and anchoring for therapeutic applications such as antibody or vaccine production. However, the gram-positive phenotypic trait of LAB creates challenges for genetic modifications when compared to other conventional workhorse bacteria, resulting in exclusive developments of genetic tools for engineering LAB. In this review, several distinct approaches in gene expression for engineering LAB are discussed.
-
5.
Plasma Lactate as a Marker for Metabolic Health.
Broskey, NT, Zou, K, Dohm, GL, Houmard, JA
Exercise and sport sciences reviews. 2020;(3):119-124
-
-
Free full text
-
Abstract
Blood lactate concentrations traditionally have been used as an index of exercise intensity or clinical hyperlactatemia. However, more recent data suggest that fasting plasma lactate can also be indicative of the risk for subsequent metabolic disease. The hypothesis presented is that fasting blood lactate accumulation reflects impaired mitochondrial substrate use, which in turn influences metabolic disease risk.
-
6.
Impact of Pre-exercise Hypohydration on Aerobic Exercise Performance, Peak Oxygen Consumption and Oxygen Consumption at Lactate Threshold: A Systematic Review with Meta-analysis.
Deshayes, TA, Jeker, D, Goulet, EDB
Sports medicine (Auckland, N.Z.). 2020;(3):581-596
Abstract
BACKGROUND Progressive exercise-induced dehydration may impair aerobic exercise performance (AEP). However, no systematic approach has yet been used to determine how pre-exercise hypohydration, which imposes physiological challenges differing from those of a well-hydrated pre-exercise state, affects AEP and related components such as peak oxygen consumption [Formula: see text] and [Formula: see text] at lactate threshold [Formula: see text]. OBJECTIVE To determine, using a systematic approach with meta-analysis, the magnitude of the effect of pre-exercise hypohydration on AEP, [Formula: see text] and [Formula: see text]. DESIGN This was a systematic review with meta-analysis of well-controlled studies. DATA SOURCES MEDLINE, SPORTDiscus and CINAHL databases and cross-referencing. INCLUSION CRITERIA FOR SELECTING STUDIES (1) well-controlled human (≥ 18 years) studies; (2) pre-exercise hypohydration induced at least 1 h prior to exercise onset; (3) pre-exercise body mass loss in the hypohydrated, experimental condition was ≥ 1% and ≥ 0.5% than the well-hydrated, control condition; (4) following the dehydrating protocol body mass change in the control condition was within - 1% to + 0.5% of the well-hydrated body mass. RESULTS A total of 15 manuscripts were included, among which 14, 6 and 6 met the inclusion criteria for AEP, [Formula: see text] and [Formula: see text], respectively, providing 21, 10 and 9 effect estimates, representing 186 subjects. Mean body mass decrease was 3.6 ± 1.0% (range 1.7-5.6%). Mean AEP test time among studies was 22.3 ± 13.5 min (range 4.5-54.4 min). Pre-exercise hypohydration impaired AEP by 2.4 ± 0.8% (95% CI 0.8-4.0%), relative to the control condition. Peak oxygen consumption and [Formula: see text], respectively, decreased by 2.4 ± 0.8% (95% CI 0.7-4.0%) and 4.4 ± 1.4% (95% CI 1.7-7.1%), relative to the control condition. Compared with starting an exercise hypohydrated, it is respectively likely, possible and likely that AEP, [Formula: see text] and [Formula: see text] benefit from a euhydrated state prior to exercise. Meta-regression analyses did not establish any significant relationship between differences in body mass loss and differences in the percent change in AEP or [Formula: see text]. However, [Formula: see text] was found to decrease by 2.6 ± 0.8 % (95% CI 0.7-4.5%) for each percent loss in body mass above a body mass loss threshold of 2.8%. CONCLUSION Pre-exercise hypohydration likely impairs AEP and likely reduces [Formula: see text] (i.e., the aerobic contribution to exercise was lower) during running and cycling exercises ≤ 1 h across different environmental conditions (i.e., from 19 to 40 °C). Moreover, pre-exercise hypohydration possibly impedes [Formula: see text] during such exercises.
-
7.
Free lactic acid production under acidic conditions by lactic acid bacteria strains: challenges and future prospects.
Singhvi, M, Zendo, T, Sonomoto, K
Applied microbiology and biotechnology. 2018;(14):5911-5924
Abstract
Lactic acid (LA) is an important platform chemical due to its significant applications in various fields and its use as a monomer for the production of biodegradable poly(lactic acid) (PLA). Free LA production is required to get rid of CaSO4, a waste material produced during fermentation at neutral pH which will lead to easy purification of LA required for the production of biodegradable PLA. Additionally, there is no need to use corrosive acids to release free LA from the calcium lactate produced during neutral fermentation. To date, several attempts have been made to improve the acid tolerance of lactic acid bacteria (LAB) by using both genome-shuffling approaches and rational design based on known mechanisms of LA tolerance and gene deletion in yeast strains. However, the lack of knowledge and the complexity of acid-tolerance mechanisms have made it challenging to generate LA-tolerant strains by simply modifying few target genes. Currently, adaptive evolution has proven an efficient strategy to improve the LA tolerance of individual/engineered strains. The main objectives of this article are to summarize the conventional biotechnological LA fermentation processes to date, assess their overall economic and environmental cost, and to introduce modern LA fermentation strategies for free LA production. In this review, we provide a broad overview of free LA fermentation processes using robust LAB that can ferment in acidic environments, the obstacles to these processes and their possible solutions, and the impact on future development of free LA fermentation processes commercially.
-
8.
Recent advancements in lactic acid production - a review.
Eş, I, Mousavi Khaneghah, A, Barba, FJ, Saraiva, JA, Sant'Ana, AS, Hashemi, SMB
Food research international (Ottawa, Ont.). 2018;:763-770
-
9.
Neonatal mitochondrial leukoencephalopathy with brain and spinal involvement and high lactate: expanding the phenotype of ISCA2 gene mutations.
Toldo, I, Nosadini, M, Boscardin, C, Talenti, G, Manara, R, Lamantea, E, Legati, A, Ghezzi, D, Perilongo, G, Sartori, S
Metabolic brain disease. 2018;(3):805-812
Abstract
A homoallelic missense founder mutation of the iron-sulfur cluster assembly 2 (ISCA2) gene has been recently reported in six cases affected by an autosomal recessive infantile neurodegenerative mitochondrial disorder. We documented a case of a 2-month-old girl presenting with severe hypotonia and nystagmus, who rapidly deteriorated and died at the age of three months. Increased cerebral spinal fluid level of lactate, documented also at the brain spectroscopy, involvement of the cortex, restricted diffusion of white and gray matter abnormalities, sparing of the corpus callosum and extensive involvement of the spinal cord were observed. Her clinical presenting features and course as well as some neuroradiological findings mimicked those of early-onset leukoencephalopathy with brainstem and spinal cord involvement and high brain lactate (LBSL). The analysis of the mitochondrial respiratory chain function showed a reduced activity of complexes II and IV. The girl harboured two heterozygous mutations in the ISCA2 gene. A comprehensive review of the literature and a comparison with the cases of early onset LBSL enabled us to highlight significant differences in the clinical, biochemical and neuroradiological phenotype between the two conditions, which also emerged from the comparison with the other 6 reported cases of ISCA2 gene mutation previously reported. In summary, this represents the second report ever published associating ISCA2 gene mutation with a mitochondrial leukoencephalopathy, with a different genetic mechanism to the previous cases. Molecular analysis of ISCA2 should be included in the genetic panel for the diagnosis of early onset mitochondrial leukoencephalopathies.
-
10.
Lactic acid fermentation of human excreta for agricultural application.
Andreev, N, Ronteltap, M, Boincean, B, Lens, PNL
Journal of environmental management. 2018;:890-900
Abstract
Studies show that source separated human excreta have a fertilizing potential with benefits to plant growth and crop yield similar or exceeding that of mineral fertilizers. The main challenges in fertilizing with excreta are pathogens, and an increased risk of eutrophication of water bodies in case of runoff. This review shows that lactic acid fermentation of excreta reduces the amount of pathogens, minimizes the nutrient loss and inhibits the production of malodorous compounds, thus increasing its agricultural value. Pathogens (e.g., Enterobacteriacea, Staphylococcus and Clostridium) can be reduced by 7 log CFUg-1 during 7-10 days of fermentation. However, more resistant pathogens (e.g. Ascaris) are not always efficiently removed. Direct application of lacto-fermented faeces to agriculture may be constrained by incomplete decomposition, high concentrations of organic acids or insufficient hygienization. Post-treatment by adding biochar, vermi-composting, or thermophilic composting stabilizes and sanitizes the material. Pot and field experiments on soil conditioners obtained via lactic acid fermentation and post treatment steps (composting or biochar addition) demonstrated increased crop yield and growth, as well as improved soil quality, in comparison to unfertilized controls.